Literature DB >> 7955734

[A case of multiple sclerosis associated with granulomatous panuveitis].

F Moriwaka1, K Tashiro, T Fukazawa, R Miyagishi, Y Sasamoto.   

Abstract

A case of multiple sclerosis (MS) associated with granulomatous panuveitis was reported. A 45-year-old woman developed diplopia in 1972, at age 24, optic neuritis in 1974 and acute transverse myelopathy in 1981. Subsequently, while being under our care with the clinical diagnosis of MS, right abducens palsy in 1989, deterioration of paraparesis with remission in 1991, and weakness of left arm in 1992 occurred. CSF study revealed high IgG index and brain MRI showed multiple abnormal intensity areas in the deep white matter and periventricular areas bilaterally. On the beginning in March, 1993, she noticed left hazy vision and the ophthalmological examinations revealed marked mutton-fat like keratic precipitates, posterior synechiae, cells and flare in anterior chamber, retinal phlebitis and snow ball vitreous opacity. Granulomatous panuveitis was diagnosed and treated by topical steroid with improvement within two months. During this episode, no neurological deterioration was seen. Granulomatous uveitis in MS was rarely documented in the literatures, but this seems to be more common in women, mildly symptomatic or asymptomatic and responds well to topical steroid treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7955734

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

2.  Granulomatous Panuveitis in Multiple Sclerosis: A Rare Occurrence.

Authors:  Rutul Shah; Rohan R Mahale; Kalpana Babu; Dhwani Shah; Manu Vincent; Satabdi Nanda; T A Sangeeth; Neeharika Sriram; Ravindu Tiwari; Hansashree Padmanabha; Pooja Mailankody; Mathuranath S Pavagada
Journal:  Ann Indian Acad Neurol       Date:  2022-02-01       Impact factor: 1.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.